Free Trial

COSCIENS Biopharma (CSCI) SEC Filings & 10K Form

$3.40 +0.15 (+4.62%)
(As of 11:36 AM ET)

Recent COSCIENS Biopharma SEC Filings

DateFilerForm TypeView
10/08/2024
6:30 AM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
4:29 PM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
6:30 AM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
1:04 PM
COSCIENS Biopharma Inc. (Subject)
COSCIENS Biopharma (Subject)
Goodwood Inc. (Filed by)
Form SC 13D
08/27/2024
6:30 AM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2024
7:05 AM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2024
7:05 AM
COSCIENS Biopharma Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
2:36 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2024
8:20 AM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2024
12:31 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2024
12:46 PM
Aeterna Zentaris Inc. (Subject)
COSCIENS Biopharma (Subject)
Goodwood Inc. (Filed by)
Form SC 13G
06/04/2024
11:15 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form EFFECT
06/04/2024
11:15 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form EFFECT
06/04/2024
11:15 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form EFFECT
05/30/2024
8:55 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form POS AM
05/30/2024
8:56 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form POS AM
05/30/2024
8:56 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form POS AM
05/30/2024
8:58 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/29/2024
8:31 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K/A
05/17/2024
7:00 AM
Aeterna Zentaris Inc. (Subject)
COSCIENS Biopharma (Subject)
Form FWP
05/17/2024
7:00 AM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
11:15 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form EFFECT
05/01/2024
3:51 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2024
9:28 AM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2024
7:00 AM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2024
7:00 AM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2024
7:05 AM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/15/2024
8:33 AM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 20-F/A
12/22/2023
3:42 PM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K/A
12/14/2023
6:50 AM
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Aeterna Zentaris Inc. (Filer)
COSCIENS Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CSCI) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners